After seeing this information, Guo Yuan lost interest in brain-computer interfaces.
The narrator didn't give him any hints either.
So after Guo Yuan closed the file, he asked 01, "01, are the modifications to 02 complete?"
"It has been modified according to your requirements. Now I have 100% control over 02 and can control 02 at will."
Guo Yuan nodded in satisfaction and called Cheng Shuqing in.
"Shu Qing, please call all the company's senior executives over for a meeting."
"Okay, boss."
A few minutes later, the executives of Future Technology arrived at the office.
"Boss, did you call us?" CEO Wang Hui asked, taking the lead.
"Okay, I've finished debugging 02, I'll send it out to you now."
Apart from Wang Hui, the executives at Future Technology were all completely bewildered.
02? What's that?
Guo Yuan didn't explain much to them. He asked them to bring their phones over and then connected them to the computer one by one, having 01 replace the voice assistant on their phones with 02.
"Alright, that's all set. Wang Hui will explain the specific functions of 02 to you!" After saying that, Guo Yuan handed the phone back to the five people.
The executives of Future Technology came in looking completely bewildered, and they left looking completely bewildered.
"Old Wang, what exactly is 02?" Tong Qifeng asked.
"I had dinner with my boss and CEO Lei and CEO Lu from Da Mi before, and my boss brought out one of them."
After hearing Wang Hui's description, Zhao Liyi and Xun Haoran, who were tech-savvy, immediately thought it was nonsense. This was impossible! Current artificial intelligence modules could not possibly reach that level.
Although Zhuge Chuang is not a technologist, he has a fairly good understanding of internet companies because when his own company was on the verge of bankruptcy, he frequently sought sponsorship from these companies.
Zhuge Chuang also felt that Wang Hui's words were a bit far-fetched.
Liu Xiaoyin and Tong Qifeng, who lacked technical knowledge and understanding of internet companies, have already begun to try it out.
"Can 02 help me connect to the surveillance cameras in my daughter's class?" Liu Xiaoyin made a very difficult request.
Two seconds later, 02's mechanical voice came through the receiver. "Connected."
Then Liu Xiaoyin's phone screen showed the surveillance footage of her daughter's classroom.
"Damn it! Everyone, I have something to do, I'm leaving." Zhao Liyi, who witnessed this scene, ran away immediately.
Xun Haoran and Zhuge Chuang a glance and then ran off.
For the next two days, the executives of Future Technology were immersed in the powerful functions of 02.
In addition to the executives of Future Technology, Guo Yuan also contacted Lin Yumo and used her to give 02 to Su Yurou.
To be honest, personally speaking, Guo Yuan felt that Su Yurou was more trustworthy than the senior executives in his company.
Moreover, he ultimately had control of 02, so he gave it away.
After Guo Yuan replaced the voice assistant on Su Yurou's phone with 02, Su Yurou didn't care much at first, but after trying it for a while, Su Yurou also got hooked.
After the initial novelty wore off in the first few days, the executives of Future Technology and Su Yurou both calmed down.
Through these few days of exploration, they have basically figured out the function of 02.
After the initial novelty wore off, 02 became just another office aid.
Meanwhile, Musk's assistant Fiona emerged from FDA headquarters, looking somewhat dejected.
Despite the pressure from so many disabled people, the FDA has not budged and has been dragging its feet.
Musk's companies, such as Tesla which makes electric cars and SpaceX which makes rockets, have always solved problems using an engineer's approach.
It doesn't necessarily pursue breakthroughs in principles, but rather focuses on addressing unavoidable technical problems, developing a series of technological improvements, and accumulating quantitative changes to achieve qualitative changes.
The same applies to brain-computer interfaces. Since craniotomy is too complex, we develop specialized surgical robots. Since rejection reactions limit the lifespan of electrodes, we develop flexible electrodes that are smaller and more biocompatible.
The ultimate goal is to make brain-computer interface devices products that ordinary families can use at any time, rather than treatments that require expert operation.
But it is precisely this model that makes human trials so important for Neuralink.
If the human trials fail, Neuralink's implantable brain-computer interface technology will come to a standstill. Not to mention the previous investments, the subsequent costs will continue to increase.
This is one of the reasons why Musk is in such a hurry.
Besides this reason, other brain-computer interface companies in the USA are also at a high level of development. Musk currently only has a slight technological lead, which is likely to be surpassed by others very soon.
To put it bluntly, Musk is working alone, and the development of implantable brain-computer interfaces is actually an interdisciplinary and cross-domain project.
It requires collaboration from experts in various fields, including computer science, neurobiology, engineering, and surgery.
Currently, most of the world's influential implantable brain-computer interface teams have backgrounds in prestigious universities and hospitals.
Take Blackstone Neuroscience, for example, which has completed 32 out of 36 human brain-computer interface implantations worldwide.
This company has received support from Brown University, Harvard Medical School, Massachusetts General Hospital, and Providence Veterans Affairs Medical Center.
Blackstone's exclusive technology is "BrainGate," which implants electrodes in the patient's brain and arm. Through a signal conversion system, it communicates with a computer, allowing spinal cord injury patients to regain control of their limbs, disabled people to control mechanical prosthetics, and even restore touch.
In addition to Blackstone, Stanford University also has a brain-computer interface team, funded by the Howard Hughes Medical Center.
There is also a neural synchronization company whose founder completed the invention at the University of Melbourne in Australia and subsequently received funding from the USA government.
In addition, there is Hodak, who originally co-founded Neuralink with Musk, who started his own business and collaborated with MIT to develop a brain-computer interface targeting the visual neural center.
In contrast, Musk's Neuralink is an outlier, unwilling to have too close a relationship with universities or hospitals.
Currently, Neuralink's implantable electrode device is only the size of a coin and integrates a chip that can perform many signal data processing tasks at the front end.
Compared to general brain-computer interfaces developed by several other teams, Neuralink's product looks closer to large-scale clinical application.
However, with so many universities and hospitals collaborating with each other, Neuralink's technological lead is actually quite easy to overtake.
"Boss, the FDA hasn't given in," Fiona reported to Musk after returning to the company.
Musk wasn't surprised by this. To be honest, Musk felt from the beginning that Fiona's chosen method of applying pressure was not very effective.
The reason is simple: the FDA values its own interests more than the demands of people with disabilities.
"Fiona, let's put Neuralink on hold for now!" Musk said expressionlessly, leaning back in his chair.
"Put it aside? But boss..."
"We can still afford these losses for now. I've thought about it these past few days, and our best option is not to fight to the death, but to find another way," Musk interrupted Fiona.
"Find another way?"
"That's right, remember the self-driving technology I mentioned before?"
"Boss, do you mean you want to expand Tesla's influence first?"
"That's right. Once Tesla's influence expands further, we can influence more people and more departments, get them to put pressure on us, to the point that the FDA has to distance itself from those who influenced them, and then our application will be approved. That's the best way to get approval from the FDA," Musk said.
After a moment of silence, Fiona retorted, "But boss, our autonomous driving technology is unlikely to make any breakthroughs in the short term."
"So I plan to have a good talk with Future Technology. I want to know if they have the technical capability to break through to Level 3 autonomous driving."
If Future Technology can overcome this technological bottleneck, the board of directors has already agreed to allocate 10 million shares to Future Technology.
"10 million shares!" Fiona exclaimed in surprise, "Boss, are you serious?"
Musk nodded, his expression incredibly serious at that moment.
Tesla currently has approximately 2 billion shares, and 10 million shares are roughly equivalent to 0.5% of Tesla's stock.
It's worth noting that Tesla's market capitalization is in the trillions of US Dollar.
Even 0.5% of the shares can be worth 5 billion US Dollar.
Is it really worth 5 billion US Dollar for L3 autonomous driving technology?
Musk seemed to see through Fiona's thoughts and said with a smile, "Fiona, these 10 million shares are not just about buying L3 autonomous driving technology, but also about buying Future Technology and advancing together with us."
If they can really help us break through the technology of L3 autonomous driving, then they may be able to help us break through L4 or even L5 in the future.
If you think about it that way, even 20 million shares would be worthwhile, let alone 10 million!
"Boss, the board of directors can't possibly agree to 20 million shares, can they?" Fiona said weakly.
Musk smiled. Indeed, the board of directors would not approve giving Future Technology 20 million shares, because holding 1% of Tesla's shares, based on Tesla's current shareholding structure, would already qualify one to participate in Tesla's board of directors. Wouldn't that be equivalent to giving away one's own power?
"Boss, how can you confirm whether Future Technology has such a technological means?" Fiona asked.
"Then I'll naturally go to China, but I don't want to make this a public issue. Fiona, you should know how to handle this, right?"
"I understand, boss. Don't worry, I'll handle everything."
Musk nodded in satisfaction.
Musk really likes this assistant very much; he is quick-witted, capable, and impeccable in interpersonal relationships.
The only drawback is that we don't have a clear enough understanding of the rules of this world.
The decision to use the naive tactic of appealing to the public's sympathy for people with disabilities to pressure the FDA demonstrates a lack of understanding of the rules of the game.
Fortunately, she is still young, not even 30 years old this year, so she has plenty of time to grow.